Anti-B4GALNT2 aptamer SELEX Service(Cat#: CTApt-1904)

This is an aptamer development services to screening aptamers binds to the B4GALNT2 with an affinity of 1nM~1μM.

Datasheet MSDS COA
Specific Inquiry 
Size
5’ Modification
 
3’ Modification
 
Add To
Online Inquiry

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number

TOP
Summary

Specifications
Target Category Protein
Target B4GALNT2
Alternative Names Beta-1,4-N-Acetyl-Galactosaminyltransferase 2; UDP-GalNAc:Neu5Acalpha2-3Galbeta-R Beta1,4-N-Acetylgalactosaminyltransferase; UDP-GalNAc:Neu5Aca2-3Galb-R B1,4-N-Acetylgalactosaminyltransferase; Beta-1,4 N-Acetylgalactosaminyltransferase 2; Sd(A) Beta-1,4-GalNAc Transferase; GALGT2; Beta 1,4 N-Acetylgalactosaminyltransferase/Betal,4 GalNAcT/Sda-GalNAcT; Beta-1,4-N-Acetyl-Galactosaminyl Transferase 2; Beta-4-N-Acetylgalactosaminyltransferase; Sda Beta-1,4-GalNAc Transferase; B4GALNT2; B4GALT; Sda; Cad
Gene ID 124872
UniProt ID Q8NHY0
Target Overview B4GALNT2 catalyzes the last step in the biosynthesis of the human Sd(a) antigen through the addition of an N-acetylgalactosamine residue via a beta-1,4 linkage to a subterminal galactose residue substituted with an alpha-2,3-linked sialic acid. B4GALNT2 also catalyzes the last step in the biosynthesis of the Cad antigen (Montiel et al., 2003 [PubMed 12678917]).
Chemical Modification N/A
Type DNA
Length 20-80 nt
Affinity (Kd) 1nM~1μM
Binding Conditions/Buffer PBS; buffer system with Serum; other
For Research Use Only. Not for Diagnostic or Therapeutic Applications.
Online Inquiry
×